FDA.reportPublic FDA data

AFINITOR DISPERZ 2 MG Tablet for Oral Suspension

RxCUI
1310138
RxNorm name
AFINITOR DISPERZ 2 MG Tablet for Oral Suspension
Display name
AFINITOR DISPERZ 2 MG Tablet for Oral Suspension
Full name
AFINITOR DISPERZ 2 MG Tablet for Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
2150f73a-179b-4afc-b8ce-67c85cc72f04AFINITOR DISPERZ 2 MG Tablet for Oral SuspensionPSN66These highlights do not include all the information needed to use AFINITOR/AFINITOR DISPERZ safely and effectively. See full prescribing information for AFINITOR/AFINITOR DISPERZ. AFINITOR ® (everolimus) tablets, for oral use AFINITOR DISPERZ ® (everolimus tablets for oral suspension) Initial U.S. Approval: 200920260212
2150f73a-179b-4afc-b8ce-67c85cc72f04everolimus 2 MG Tablet for Oral Suspension [Afinitor]SBD66These highlights do not include all the information needed to use AFINITOR/AFINITOR DISPERZ safely and effectively. See full prescribing information for AFINITOR/AFINITOR DISPERZ. AFINITOR ® (everolimus) tablets, for oral use AFINITOR DISPERZ ® (everolimus tablets for oral suspension) Initial U.S. Approval: 200920260212
2150f73a-179b-4afc-b8ce-67c85cc72f04Afinitor Disperz 2 MG Tablet for Oral SuspensionSY66These highlights do not include all the information needed to use AFINITOR/AFINITOR DISPERZ safely and effectively. See full prescribing information for AFINITOR/AFINITOR DISPERZ. AFINITOR ® (everolimus) tablets, for oral use AFINITOR DISPERZ ® (everolimus tablets for oral suspension) Initial U.S. Approval: 200920260212